Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Osiris Therapeutics Company Profile (NASDAQ:OSIR)

Consensus Ratings for Osiris Therapeutics (NASDAQ:OSIR) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.00 (4.68% upside)

Analysts' Ratings History for Osiris Therapeutics (NASDAQ:OSIR)
Show:
DateFirmActionRatingPrice TargetActions
3/19/2015Brean CapitalReiterated RatingBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Brean CapitalSet Price TargetBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Brean CapitalSet Price TargetBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2014Brean CapitalInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014R. F. LaffertyInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013Piper JaffrayUpgradeNeutral -> Overweight$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2013Jefferies GroupBoost Price TargetUnderperform$3.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2013Piper JaffrayDowngradeOverweight -> Neutral$14.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)